tiprankstipranks
Beam Therapeutics outlines key 2025 anticipated catalysts
PremiumThe FlyBeam Therapeutics outlines key 2025 anticipated catalysts
17d ago
Beam Therapeutics sees cash runway into 2027
Premium
The Fly
Beam Therapeutics sees cash runway into 2027
17d ago
Beam Therapeutics upgraded to Outperform from Market Perform at Bernstein
Premium
The Fly
Beam Therapeutics upgraded to Outperform from Market Perform at Bernstein
22d ago
Beam presents new NHP data demonstrating proof-of-concept for ESCAPE
PremiumThe FlyBeam presents new NHP data demonstrating proof-of-concept for ESCAPE
2M ago
Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101
Premium
The Fly
Beam Therapeutics announces new data from BEACON Phase 1/2 trial of BEAM-101
2M ago
Beam Therapeutics Names Sravan K. Emany as CFO
Premium
Company Announcements
Beam Therapeutics Names Sravan K. Emany as CFO
2M ago
Beam Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyBeam Therapeutics participates in a conference call with JPMorgan
3M ago
Beam Therapeutics upgraded to Outperform from Market Perform at Leerink
Premium
The Fly
Beam Therapeutics upgraded to Outperform from Market Perform at Leerink
3M ago
Beam Therapeutics Reports Steady Progress in Q3 2024
Premium
Company Announcements
Beam Therapeutics Reports Steady Progress in Q3 2024
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100